Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05479890 · ClinicalTrials.gov registry record · NA
ClientBot: a Conversational Agent That Supports Skills Practice and Feedback for Motivational Interviewing
A NA study, sponsored by Lyssn.io.
- Completed
- Registry status
- NA
- Development phase
- 164
- Enrollment target
NCT05479890: Completed NA study, sponsored by Lyssn.io.
NCT05479890 is a NA study that has completed, run by Lyssn.io. The registered enrollment target is 164 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05479890, a NA study, has completed, sponsored by Lyssn.io.
- COMPLETED
- Registry status
- NA
- Development phase
- 164 participants
- Enrollment target
Study Summary
This multi-stage study includes qualitative interviews, usability research, and a randomized training study of technology implementation in a real-world clinical setting. The proposed study will enhance and evaluate an artificial intelligence (AI) based, conversational agent (ClientBot) that simulates a realistic client with alcohol concerns and provides performance-based feedback to support counselor training. The research is in collaboration with PRI, which focuses on training alcohol and substance use counselors.
Primary Outcome
The CASPI measures clinician effective use of Motivational Interviewing
Interventions
- OTHER ClientBot
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2023-01-31 |
| Est. Completion | 2024-11-10 |
| Phase | NA |
What the finished NCT05479890 record still lists
NCT05479890 is an interventional study that assigns participants to a tested intervention. The registered 164 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 1 intervention - of which ClientBot is the first listed.
NCT05479890 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05479890 about?
NCT05479890 is a clinical study titled "ClientBot: a Conversational Agent That Supports Skills Practice and Feedback for Motivational Interviewing". This multi-stage study includes qualitative interviews, usability research, and a randomized training study of technology implementation in a real-world clinical setting. The proposed study will enhance and evaluate an artificial intelligence (AI) based, conversational agent (ClientBot) that simulat...
What is the current status of trial NCT05479890?
This trial is currently completed. It is a NA study. The enrollment target is 164 participants. The study started on 2023-01-31. Estimated completion is 2024-11-10.
What interventions are being tested in trial NCT05479890?
The interventions under investigation include: ClientBot (OTHER).
Who is sponsoring clinical trial NCT05479890?
This trial is sponsored by Lyssn.io, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05479890's enrollment target sits among peer trials
164 626th of 2000 higher than 1,374 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04891289 · 164 participants · Phase 2
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
- NCT04893226 · 164 participants · NA
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
- NCT05270213 · 164 participants · Phase 1
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
- NCT05543681 · 164 participants · Phase 2
Clinical Trial on Agitation in Alzheimer's Dementia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI